These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32550367)

  • 1. Establishment of a CRISPR/Cas9-based strategy for inducible protein dimerization.
    Zielich J; Mangal S; Zanin E; Lambie E
    MicroPubl Biol; 2018 Apr; 2018():. PubMed ID: 32550367
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum: Establishment of a CRISPR/Cas9-based strategy for inducible protein dimerization.
    MicroPubl Biol; 2019 Dec; 2019():. PubMed ID: 32550649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a baculovirus-inducible CRISPR/Cas9 system for antiviral research in transgenic silkworms.
    Dong Z; Huang L; Dong F; Hu Z; Qin Q; Long J; Cao M; Chen P; Lu C; Pan MH
    Appl Microbiol Biotechnol; 2018 Nov; 102(21):9255-9265. PubMed ID: 30151606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
    Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
    J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manipulating Living Systems by Light].
    Sato M
    Yakugaku Zasshi; 2020; 140(8):993-1000. PubMed ID: 32741873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing.
    Degreif D; Kremenovic M; Geiger T; Bertl A
    J Biol Methods; 2018; 5(3):e98. PubMed ID: 31453248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system.
    Liu R; Chen L; Jiang Y; Zhou Z; Zou G
    Cell Discov; 2015; 1():15007. PubMed ID: 27462408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tetracycline-inducible CRISPR/Cas9 system, targeting two long non-coding RNAs, suppresses the malignant behavior of bladder cancer cells.
    Peng L; Pan P; Chen J; Yu X; Wu J; Chen Y
    Oncol Lett; 2018 Oct; 16(4):4309-4316. PubMed ID: 30214566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
    Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
    Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient CRISPR/Cas9-Mediated Gene Editing in an Interspecific Hybrid Poplar With a Highly Heterozygous Genome.
    Wang J; Wu H; Chen Y; Yin T
    Front Plant Sci; 2020; 11():996. PubMed ID: 32719704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A piggyBac-based toolkit for inducible genome editing in mammalian cells.
    Schertzer MD; Thulson E; Braceros KCA; Lee DM; Hinkle ER; Murphy RM; Kim SO; Vitucci ECM; Calabrese JM
    RNA; 2019 Aug; 25(8):1047-1058. PubMed ID: 31101683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing.
    Lu J; Zhao C; Zhao Y; Zhang J; Zhang Y; Chen L; Han Q; Ying Y; Peng S; Ai R; Wang Y
    Nucleic Acids Res; 2018 Mar; 46(5):e25. PubMed ID: 29237052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing.
    de Solis CA; Ho A; Holehonnur R; Ploski JE
    Front Mol Neurosci; 2016; 9():70. PubMed ID: 27587996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge.
    Lee C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing of
    Nagaraju S; Davies NK; Walker DJ; Köpke M; Simpson SD
    Biotechnol Biofuels; 2016; 9():219. PubMed ID: 27777621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System.
    Gao Z; Herrera-Carrillo E; Berkhout B
    Mol Ther Nucleic Acids; 2019 Mar; 14():32-40. PubMed ID: 30530211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Inducible CRISPR/Cas Systems.
    Zhang J; Chen L; Zhang J; Wang Y
    Comput Struct Biotechnol J; 2019; 17():1171-1177. PubMed ID: 31462973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
    Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
    ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.